Baxter(US:BAX) Newsfile·2025-11-07 00:16Core Viewpoint - Rosen Law Firm is reminding investors who purchased Baxter International Inc. common stock between February 23, 2022, and July 30, 2025, of the December 15, 2025, deadline to become a lead plaintiff in a class action lawsuit [2][4]. Group 1: Class Action Details - Investors who bought Baxter common stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must act by December 15, 2025, to serve as lead plaintiff [4][6]. - The lawsuit alleges that Baxter misled investors regarding the safety and efficacy of the Novum IQ Large Volume Pump, which suffered systemic defects leading to serious risks for patients [6]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [5]. - The firm has been recognized for its achievements in securities class action settlements, including a notable settlement against a Chinese company and ranking highly in the number of settlements since 2013 [5]. Group 3: Case Specifics - The lawsuit claims that Baxter was aware of multiple malfunctions and injuries related to the Novum LVP but failed to adequately address these issues, leading to misleading statements about the product's safety and sales prospects [6].